Literature DB >> 21751072

Recurarization after sugammadex reversal in an obese patient.

Frédérique Le Corre1, Salmi Nejmeddine, Chérif Fatahine, Claude Tayar, Jean Marty, Benoît Plaud.   

Abstract

PURPOSE: We report a case that involved immediate postoperative respiratory failure necessitating tracheal intubation, which was possibly related to recurarization after sugammadex reversal. CLINICAL
FINDINGS: A 54-yr-old woman weighing 115-kg was scheduled for laparoscopic repair of abdominal dehiscence under general anesthesia. Muscle relaxation was induced and maintained with rocuronium (170 mg iv total dose). At the end of the 170-min procedure, two twitches were visualized after supramaximal train-of-four (TOF) stimulation at the adductor pollicis muscle, and the patient's central core temperature was 35.6°C. Sugammadex 200 mg iv (1.74 mg·kg(-1)) was administered. With the patient fully awake, a TOF ratio 0.9 was obtained five minutes later. The tracheal tube was then removed, and the patient was transferred to the postanesthesia care unit. Ten minutes later, the patient presented respiratory failure necessitating tracheal intubation and sedation with propofol. One TOF response only was visualized at the adductor pollicis muscle. Another dose of sugammadex 200 mg iv was administered. Forty-five minutes later, the patient was fully awake and her trachea was extubated after repeated measures of the TOF ratio (≥ 0.9) at the adductor pollicis muscle. The patient fully recovered without sequelae, further complication, or prolonged hospital stay.
CONCLUSION: Shortly after tracheal extubation, an obese patient experienced respiratory failure necessitating tracheal intubation and an additional dose of sugammadex. This occurred despite initial reversal of neuromuscular blockade with an appropriate dose of sugammadex 2 mg·kg(-1) iv given at two responses to TOF stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21751072     DOI: 10.1007/s12630-011-9554-y

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  Estimation of the success rate of anesthetic management for thymectomy in patients with myasthenia gravis treated without muscle relaxants: a retrospective observational cohort study.

Authors:  Yoshihito Fujita; Satoru Moriyama; Satoshi Aoki; Saya Yoshizawa; Maiko Tomita; Taiki Kojima; Yukiko Mori; Naoko Takeuchi; Min-Hye So; Motoki Yano; Kazuya Sobue
Journal:  J Anesth       Date:  2015-03-22       Impact factor: 2.078

2.  Anesthetic Pharmacology and the Morbidly Obese Patient.

Authors:  Jerry Ingrande; Hendrikus Jm Lemmens
Journal:  Curr Anesthesiol Rep       Date:  2012-12-13

3.  Postoperative Respiratory Failure in a Patient with Undiagnosed Myastenia Gravis.

Authors:  Funda Özel; Ali Aydın Altunkan; Mustafa Azizoğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-04-01

Review 4.  [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].

Authors:  C Unterbuchner; K Ehehalt; B Graf
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

5.  Residual paralysis caused by 50 mg rocuronium after reversal with 4 mg/kg sugammadex: a case report.

Authors:  Kohji Uzawa; Hiroyuki Seki; Tomoko Yorozu
Journal:  BMC Anesthesiol       Date:  2021-05-20       Impact factor: 2.217

6.  Sugammadex and ideal body weight in bariatric surgery: the debate continues.

Authors:  Michele Carron
Journal:  Anesthesiol Res Pract       Date:  2014-03-13

Review 7.  Preparing for the unexpected: special considerations and complications after sugammadex administration.

Authors:  Hajime Iwasaki; J Ross Renew; Takayuki Kunisawa; Sorin J Brull
Journal:  BMC Anesthesiol       Date:  2017-10-17       Impact factor: 2.217

8.  What we need to know on timing principle of nondepolarizing muscle relaxant administration.

Authors:  A Uvelin; A Sunjkić
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

Review 9.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

10.  Reversal agents in anaesthesia and critical care.

Authors:  Nibedita Pani; Pradeep A Dongare; Rajeeb Kumar Mishra
Journal:  Indian J Anaesth       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.